OnCo
institutionsInstitution

Alliance for Clinical Trials in Oncology

US cooperative group formed from CALGB, ACOSOG, and NCCTG; running OptimICE-pCR, which asks whether TNBC patients with a complete response still need a year of immunotherapy.

Formed 2011. NCI National Clinical Trials Network member. Trials include CALGB 40603 (carboplatin in TNBC), Z0011 (sentinel node without dissection), and A012103/OptimICE-pCR (omitting adjuvant pembrolizumab after pathologic complete response).

Location
Chicago, IL, US
Type
consortium
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#93 · 34 points (0 Newsweek + 0 NCI + 34 from 17 linked objects) · ranking

Programmes

3top
  • NCTN cooperative group
  • OptimICE-pCR
  • Breast surgical de-escalation (Z0011)

People

2top

Connected

19top

Pages like this

not linked directly; found by shared links